Cu-Based Nanoagent Could Boost Nanocatalytic Medicine
| Date | 8th, Jul 2022 |
|---|---|
| Source | AZoNano - Nanotechnology Websites |
DESCRIPTION
Although chemodynamic therapy is a potential anti-tumor strategy, its inefficiency in generating reactive oxygen species (ROS) restricts its clinical translation. In an article recently published in the journal Biomaterials, researchers constructed a liposomal nanosystem to co-encapsulate artemisinin (ART) and copper peroxide nanodots (CPNs) for ferroptosis-involved, autophagy-enhanced cancer cell apoptosis.